对国内众多的网络、医药等高科技企业来说,选择美国纳斯达克上市是铸造其高成长神话的一个捷径。然而,自2006年7月15日起,随着萨班斯法案的正式实施对中国众多的中小企业而言,美国证券市场正在变得越来越遥远。就在这时,老牌证券交易所——伦敦证券交易所,向内地的中小企业伸出了橄榄枝,“到伦敦上市去!”也因此成为国内企业海外上市的又一全新选择。 For many domestic networks, pharmaceuticals and other high-tech enterprises, the choice of the United States Nasdaq listing is a shortcut to casting its high growth myth. However, as of July 15, 2006, with the formal implementation of the Sarbanes-Oxley Act for many SMEs in China, the U.S. securities market is becoming increasingly distant. Just then, the established stock exchange, the London Stock Exchange, has extended its olive branch to the mainland SMEs and “going to London to go public” has thus become another brand new option for domestic companies to go public overseas.